Add to Calendar 9/9/2019 10:00:00 AM 9/9/2019 5:00:00 PM Digital Health Impact 2019

Online registration is now closed, there will be a limited number of onsite registrations on Monday

The convergence between digital health and the life sciences is creating new opportunities to transform patient care as well as drug discovery and development. From wearables to machine learning, digital technologies are easing data collection from patients, increasing medical adherence, reshaping clinical trials, and offering new insights into real-world applications of therapies. Embedding digital health tools into the life sciences will also allow new therapies to better work within the growing value-based healthcare system that relies on data and measurable outcomes.

Join MassBio for our inaugural Digital Health Impact 2019 event at the InterContinental Boston at 510 Atlantic Ave, Boston, MA 02210, part of Biotech Week Boston, as we examine the current state of digital health as it relates to the life sciences, the challenges facing its growth, and opportunities for collaboration. Through keynotes, panel discussions, and case studies, we’ll explore new strategies for life sciences and digital health innovators to converge and ultimately deliver better outcomes for patients. Contact Laura Rudberg for sponsorship opportunities. View our sponsorship prospectus here. 

 Intercontinental Boston, 510 Atlantic Avenue, Boston MA, 02210
CCO, EVP & Co-Founder, GNS Healthcare
Dr. Iya Khalil is a technology entrepreneur and physicist with a vision of transforming medicine and healthcare into a discipline that is quantitative, predictive, and patient-centric via AI and big data. She co-founded two AI and machine learning companies, Gene Network Sciences Inc. and GNS Healthcare, and is the co-inventor of the proprietary AI and machine learning software platform that underpins both entities. Dr. Khalil’s machine learning and AI expertise spans 18 years with applications in drug discovery, drug development, clinical trial optimization, real world evidence and pharmaceutical commercial applications, and all the way to treatment algorithms that can be applied at the point of care. She is a frequent speaker at industry conferences including Exponential Medicine, Milken Global Conference, Health 2.0, SXSW, Bio, and TEDX and was recently profiled in Forbes Magazine as one of the women making artificial intelligence more accessible and less scary. Dr. Khalil has published extensively in AI and machine learning for healthcare, including peer-reviewed journal articles and poster presentations at scientific conferences such as ASCO, AACR, ASH, ISPOR and EASL. She was recognized by President Obama in 2014 as a leading entrepreneur in genomic medicine and more recently named to Inc’s magazine list of top female founders of 2018. Iya received her PhD and MS in Physics from Cornell University. In her spare time, she loves to advise early startups, spend time with her family and friends, travel, cook Libyan cuisine, enjoy the outdoors and is also fluent in Arabic. She is also a passionate member of Springboard enterprises, the largest network of innovators, investors and influencers who are dedicated to building high-growth women led technology companies.

Brought to you by